Abstract
Helminths have accompanied human throughout history by releasing immune-evasion molecules that could counteract an aberrant immune response within the host. In the past decades, helminth infections are becoming less prevalent possibly due to the developed sanitation. Meanwhile, the incidence of autoimmune diseases is increasing, which cannot be exclusively explained by the changes of susceptibility genes. While the hygiene hypothesis casts light on the problem. The infections of helminths are believed to interact with and regulate human immunity with the byproduct of suppressing the autoimmune diseases. Thus, helminths are potential to treat or cure the autoimmune diseases. The therapeutic progresses and possible immune suppression mechanisms are illustrated in the review. The helminths that are studied most intensively include Heligmosomoides polygyrus, Hymenolepis diminuta, Schistosoma mansoni, Trichinella spiralis, and Trichuris suis. Special attentions are paid on the booming animal models and clinical trials that are to detect the efficiency of immune-modulating helminth-derived molecules on autoimmune diseases. These trials provide us with a prosperous clinical perspective, but the precise mechanism of the down-regulatory immune response remains to be clarified. More efforts are needed to be dedicated until these parasite-derived immune modulators could be used in clinic to treat or cure the autoimmune diseases under a standard management.
Similar content being viewed by others
References
Ajendra J, Berbudi A, Hoerauf A, Hubner MP (2016) Combination of worm antigen and proinsulin prevents type 1 diabetes in NOD mice after the onset of insulitis. Clin Immunol 164:119–122
Amdare N, Khatri V, Yadav RS, Tarnekar A, Goswami K, Reddy MV (2015) Brugia malayi soluble and excretory-secretory proteins attenuate development of streptozotocin-induced type 1 diabetes in mice. Parasite Immunol 37:624–634
Ashour DS, Othman AA, Shareef MM, Gaballah HH, Mayah WW (2014) Interactions between Trichinella spiralis infection and induced colitis in mice. J Helminthol 88:210–218
Bager P, Vinkel HA, Wohlfahrt J, Melbye M (2012a) Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 142:55–62
Bager P, Vinkel Hansen A, Wohlfahrt J, Melbye M (2012b) Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 142:55–62
Bashi T, Bizzaro G, Ben-Ami Shor D, Blank M, Shoenfeld Y (2015) The mechanisms behind helminth's immunomodulation in autoimmunity. Autoimmun Rev 14:98–104
Becerra-Diaz M, Valderrama-Carvajal H, Terrazas LI (2011) Signal transducers and activators of transcription (STAT) family members in helminth infections. Int J Biol Sci 7:1371–1381
Behnke JM, Eira C, Rogan M, Gilbert FS, Torres J, Miquel J, Lewis JW (2009) Helminth species richness in wild wood mice, Apodemus sylvaticus, is enhanced by the presence of the intestinal nematode Heligmosomoides polygyrus. Parasitology 136:793–804
Berbudi A, Ajendra J, Wardani AP, Hoerauf A, Hubner MP (2016a) Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes. Diabetes Metab Res Rev 32:238–250
Berbudi A et al (2016b) Filarial infection or antigen administration improves glucose tolerance in diet-induced obese mice. J Innate Immun 8:601–616
Berg DJ et al (2002) Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 123:1527–1542
Bhardwaj EK, Else KJ, Rogan MT, Warhurst G (2014) Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a−/− mice. World J Gastroenterol 20:1797–1806
Blum AM, Hang L, Setiawan T, Urban JP Jr, Stoyanoff KM, Leung J, Weinstock JV (2012) Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol 189:2512–2520
Cabre P, Signate A, Olindo S, Merle H, Caparros-Lefebvre D, Bera O, Smadja D (2005) Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 128:2899–2910
Chandy A, Thakur AS, Singh MP, Manigauha A (2011) A review of neglected tropical diseases: filariasis. Asian Pac J Trop Med 4:581–586
Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517
Cooke A (2009) Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes? Immunology 126:12–17
Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, Dunne DW (1999) Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 21:169–176
Correale J, Farez M (2007) Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61:97–108
Dabelea D (2009) The accelerating epidemic of childhood diabetes. Lancet 373:1999–2000
Diamanti AP, Manuela Rosado M, Lagana B, D'Amelio R (2016) Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med 14:233
Disanto G, Ramagopalan SV (2013) On the sex ratio of multiple sclerosis. Mult Scler 19:3–4
Donskow-Lysoniewska K, Majewski P, Brodaczewska K, Jozwicka K, Doligalska M (2012) Heligmosmoides polygyrus fourth stages induce protection against DSS-induced colitis and change opioid expression in the intestine. Parasite Immunol 34:536–546
Du L et al (2011) The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice. Dig Dis Sci 56:2810–2817
Du L, Wei H, Li L, Shan H, Yu Y, Wang Y, Zhang G (2014) Regulation of recombinant Trichinella spiralis 53-kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4Ralpha in vitro. Cell Immunol 288:1–7
El-Wakil HS, Aboushousha TS, El HO, Gamil NB, Mansour T, El-Said H (2002) Effect of Schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes. J Egypt Soc Parasitol 32:987–1002
Espinoza-Jimenez A, Rivera-Montoya I, Cardenas-Arreola R, Moran L, Terrazas LI (2010) Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol 2010:850541
Ferreira I et al (2013) Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun 81:2104–2111
Finlay CM, Stefanska AM, Walsh PT, Mills KHG (2011) Immunoregulatory effects of the excretory-sectretory products of the helminth parasite Fasciola hepatica. Cytokine 56:37–37
Fleming JO, Cook TD (2006) Multiple sclerosis and the hygiene hypothesis. Neurology 67:2085–2086
Fleming JO et al (2011) Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 17:743–754
Gruden-Movsesijan A, Ilic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Milic M, Sofronic-Milosavljevic L (2008) Trichinella spiralis: modulation of experimental autoimmune encephalomyelitis in DA rats. Exp Parasitol 118:641–647
Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG (1998) alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187:1047–1056
Hang L et al (2010) Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol 185:3184–3189
Hang L, Blum AM, Setiawan T, Urban JP Jr, Stoyanoff KM, Weinstock JV (2013) Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis. J Immunol 191:1927–1934
Harnett MM, Melendez AJ, Harnett W (2010) The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol 159:256–267
Hasby EA, Hasby Saad MA, Shohieb Z, El Noby K (2015) FoxP3+ T regulatory cells and immunomodulation after Schistosoma mansoni egg antigen immunization in experimental model of inflammatory bowel disease. Cell Immunol 295:67–76
Hewitson JP, Grainger JR, Maizels RM (2009) Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol 167:1–11
Heylen M, Ruyssers NE, De Man JG, Timmermans JP, Pelckmans PA, Moreels TG, De Winter BY (2014) Worm proteins of Schistosoma mansoni reduce the severity of experimental chronic colitis in mice by suppressing colonic proinflammatory immune responses. PLoS One 9:e110002
Hubner MP, Stocker JT, Mitre E (2009) Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells. Immunology 127:512–522
Hubner MP et al (2012) Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J Immunol 188:559–568
Hunter MM, Wang A, Parhar KS, Johnston MJ, Van Rooijen N, Beck PL, McKay DM (2010) In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138:1395–1405
Imai S, Tezuka H, Fujita K (2001) A factor of inducing IgE from a filarial parasite prevents insulin-dependent diabetes mellitus in nonobese diabetic mice. Biochem Biophys Res Commun 286:1051–1058
Johnston MJ, Wang A, Catarino ME, Ball L, Phan VC, MacDonald JA, McKay DM (2010) Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun 78:1364–1375
Kaser A, Zeissig S, Blumberg RS (2010) Inflammatory bowel disease. Annu Rev Immunol 28:573–621
Keiser J, Utzinger J (2009) Food-borne trematodiases. Clin Microbiol Rev 22:466–483
Kennel De March A, De Bouwerie M, Kolopp-Sarda MN, Faure GC, Bene MC, Bernard CC (2003) Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J Neuroimmunol 135:117–125
Khan N, Smith MT (2014) Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology 22:1–22
Khan WI, Blennerhasset PA, Varghese AK, Chowdhury SK, Omsted P, Deng Y, Collins SM (2002) Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun 70:5931–5937
Khatri V, Amdare N, Tarnekar A, Goswami K, Reddy MV (2015) Brugia malayi cystatin therapeutically ameliorates dextran sulfate sodium-induced colitis in mice. J Dig Dis 16:585–594
Kondrashova A, Seiskari T, Ilonen J, Knip M, Hyoty H (2013) The ‘Hygiene hypothesis’ and the sharp gradient in the incidence of autoimmune and allergic diseases between Russian Karelia and Finland. APMIS 121:478–493
Kringel H, Roepstorff A (2006) Trichuris suis population dynamics following a primary experimental infection. Vet Parasitol 139:132–139
Krishna CS, Srikanta S (2015) Type 1 diabetes pathogenesis—prevention??? Indian J Endocrinol Metab 19:S58–S63
Kuhbacher T, Folsch UR (2007) Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol 13:1149–1155
Lalive PH et al (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 103:2280–2285
Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (1966) Epidemiological study of multiple sclerosis in Israel. II Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 29:60–68
Leung J, Hang L, Blum A, Setiawan T, Stoyanoff K, Weinstock J (2012) Heligmosomoides polygyrus abrogates antigen-specific gut injury in a murine model of inflammatory bowel disease. Inflamm Bowel Dis 18:1447–1455
Lin L, Zhang J (2017) Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol 18:2
Liu Q et al (2009) Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect Immun 77:5347–5358
Lund ME, O'Brien BA, Hutchinson AT, Robinson MW, Simpson AM, Dalton JP, Donnelly S (2014) Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One 9:e86289
Maloy KJ, Powrie F (2011) Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474:298–306
Matisz CE, Leung G, Reyes JL, Wang A, Sharkey KA, McKay DM (2015) Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice. Eur J Immunol 45:3126–3139
Matsuoka K, Hibi T (2013) Treatment guidelines in inflammatory bowel disease: the Japanese perspectives. Dig Dis 31:363–367
Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118:3420–3430
Melon A, Wang A, Phan V, McKay DM (2010) Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. J Biomed Biotechnol 2010:384523
Motomura Y, Wang H, Deng Y, El-Sharkawy RT, Verdu EF, Khan WI (2009) Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Clin Exp Immunol 155:88–95
Osada Y, Kanazawa T (2010) Parasitic helminths: new weapons against immunological disorders. J Biomed Biotechnol 2010:743758
Ostanin DV et al (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296:G135–G146
van Panhuis WG et al (2013) Contagious diseases in the United States from 1888 to the present. N Engl J Med 369:2152–2158
Patt H, Bandgar T, Lila A, Shah N (2013) Management issues with exogenous steroid therapy. Indian J Endocrinol Metab 17:S612–S617
Peres RS et al (2013) Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes. Exp Parasitol 134:183–189
Ponder A, Long MD (2013) A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol 5:237–247
Reyes JL et al (2015) Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages. J Immunol 194:364–378
Reyes JL et al (2016a) IL-22 restrains tapeworm-mediated protection against experimental colitis via regulation of IL-25 expression. PLoS Pathog 12:e1005481
Reyes JL et al (2016b) Treatment with Cestode parasite antigens results in recruitment of CCR2+ myeloid cells, the adoptive transfer of which ameliorates colitis. Infect Immun 84:3471–3483
Ruyssers NE et al (2010) Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol 16:703–712
Saunders KA, Raine T, Cooke A, Lawrence CE (2007) Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun 75:397–407
Scholmerich J et al (2016) A randomised, double-blind, placebo-controlled trial of Trichuris suis ova in active Crohn’s disease. J Crohns Colitis 11:390–399
Seiskari T et al (2007) Allergic sensitization and microbial load--a comparison between Finland and Russian Karelia. Clin Exp Immunol 148:47–52
Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z (2003) Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15:59–69
Simon F, Prieto G, Muro A, Cancrini G, Cordero M, Genchi C (1997) Human humoral immune response to Dirofilaria species. Parassitologia 39:397–400
Sofronic-Milosavljevic LJ, Radovic I, Ilic N, Majstorovic I, Cvetkovic J, Gruden-Movsesijan A (2013) Application of dendritic cells stimulated with Trichinella spiralis excretory-secretory antigens alleviates experimental autoimmune encephalomyelitis. Med Microbiol Immunol 202:239–249
Stefanska AM, Finlay CM, Mielke LA, Walsh KP, Walsh PT, Mills KH (2011) Immunomodulatory molecules from Fasciola hepatica directly suppress activation of IL-17-producing gamma delta and CD4 T cells that mediate autoimmune disease. Immunology 135:201–201
Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260
Summers RW, Elliott DE, Urban JF Jr, Thompson RA, Weinstock JV (2005) Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 128:825–832
Szkudlapski D et al (2014) The emerging role of helminths in treatment of the inflammatory bowel disorders. J Physiol Pharmacol 65:741–751
Tanabe M (2003) Haemostatic abnormalities in hepatosplenic schistosomiasis mansoni. Parasitol Int 52:351–359
Terrazas LI, Montero D, Terrazas CA, Reyes JL, Rodriguez-Sosa M (2005) Role of the programmed death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int J Parasitol 35:1349–1358
Tezuka H, Imai S, Muto R, Furuhashi Y, Fujita K (2002) Recombinant Dirofilaria immitis polyprotein that stimulates murine B cells to produce nonspecific polyclonal immunoglobulin E antibody. Infect Immun 70:1235–1244
Tezuka H, Imai S, Hidano S, Tsukidate S, Fujita K (2003) Various types of Dirofilaria immitis polyproteins selectively induce a Th2-type immune response. Infect Immun 71:3802–3811
Tuomilehto J (2013) The emerging global epidemic of type 1 diabetes. Curr Diab Rep 13:795–804
Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183:1577–1586
Wang A, Fernando M, Leung G, Phan V, Smyth D, McKay DM (2010) Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils. Am J Pathol 177:2850–2859
Whelan RA, Hartmann S, Rausch S (2012) Nematode modulation of inflammatory bowel disease. Protoplasma 249:871–886
Wilson MS et al (2010) Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 40:1682–1696
Wirtz S, Neufert C, Weigmann B, Neurath MF (2007) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:541–546
Wu Z, Nagano I, Asano K, Takahashi Y (2010) Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Parasitol Res 107:1173–1188
Yamaoka KA, Kolb JP, Miyasaka N, Inuo G, Fujita K (1994) Purified excretory-secretory component of filarial parasite enhances Fc epsilon RII/CD23 expression on human splenic B and T cells and IgE synthesis while potentiating T-helper type 2-related cytokine generation from T cells. Immunology 81:507–512
Yousefi F, Ebtekar M, Soleimani M, Soudi S, Hashemi SM (2013) Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol 17:608–616
Zaccone P, Hall SW (2012) Helminth infection and type 1 diabetes. Rev Diabet Stud 9:272–286
Zaccone P, Fehervari Z, Jones FM, Sidobre S, Kronenberg M, Dunne DW, Cooke A (2003) Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol 33:1439–1449
Zaccone P, Fehervari Z, Phillips JM, Dunne DW, Cooke A (2006) Parasitic worms and inflammatory diseases. Parasite Immunol 28:515–523
Zaccone P, Burton O, Miller N, Jones FM, Dunne DW, Cooke A (2009) Schistosoma mansoni Egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol 39:1098–1107
Zaccone P, Burton OT, Gibbs S, Miller N, Jones FM, Dunne DW, Cooke A (2010) Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol 2010:795210
Zaccone P et al (2011) The S. mansoni glycoprotein omega-1 induces Foxp3 expression in NOD mouse CD4(+) T cells. Eur J Immunol 41:2709–2718
Zhang R et al (2016) CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation. Oncotarget 7:19251–19264
Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y (2008) Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J Neuroimmunol 194:107–114
Zheng XP, Zhang HL, Li HF, Zhang MZ, Qiu W, Hu XQ (2012) Neuroprotective potential beyond immunoregulation of helminth infection as a therapeutic target in multiple sclerosis. Med Hypotheses 78:95–97
Ziegler T et al (2015) A novel regulatory macrophage induced by a helminth molecule instructs IL-10 in CD4+ T cells and protects against mucosal inflammation. J Immunol 194:1555–1564
Acknowledgements
This work was supported by grants from the National Key Research and Development Program of China (grant no. 2016YFC1202003, 2016YFC1202005 and 2016YFC1200500), Project of Basic Platform of National Science and Technology Resources of Ministry of Sciences and Technology of China (grant no. TDRC-2017-22), the National Natural Science Foundation of China (grant no. 81371836, 81572023 and 81271855), Guangdong Natural Science Foundation (grant no. 2014A030313134), Science and Technology Planning Project of Guangdong Province (grant no. 2016A050502008), Science and Technology Planning Project of Guangzhou (grant no. 201607010029), the 111 Project (grant no. B12003), the Undergraduates Innovation Training Program of Guangdong Province (grant no. 201410558274 and 201601084) and Teaching Reform Project of Sun Yat-sen University (grant no. 2016012).
Author information
Authors and Affiliations
Corresponding author
Additional information
Wang Meng, Wu Linxiang, Weng Rennan, Zheng Weihong are the joint first authors.
Rights and permissions
About this article
Cite this article
Wang, M., Wu, L., Weng, R. et al. Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance. Parasitol Res 116, 2065–2074 (2017). https://doi.org/10.1007/s00436-017-5544-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-017-5544-5